Plasma concentration and pharmacological effects of pyridostigmine in patients with myasthenia gravis [proceedings].
作者信息
Calvey T N, Chan K
出版信息
Br J Clin Pharmacol. 1977 Jun;4(3):404P. doi: 10.1111/j.1365-2125.1977.tb00750.x.
Abstract
摘要
相似文献
1
Plasma concentration and pharmacological effects of pyridostigmine in patients with myasthenia gravis [proceedings].吡啶斯的明在重症肌无力患者中的血药浓度及药理作用[会议论文集]
Br J Clin Pharmacol. 1977 Jun;4(3):404P. doi: 10.1111/j.1365-2125.1977.tb00750.x.
2
Plasma concentration of pyridostigmine and effects in myastenia gravis.吡啶斯的明的血浆浓度及其在重症肌无力中的作用。
Clin Pharmacol Ther. 1977 Nov;22(5 Pt 1):596-601. doi: 10.1002/cpt1977225part1596.
3
Neuromuscular function and plasma drug levels in pyridostigmine treatment of myasthenia gravis.吡啶斯的明治疗重症肌无力时的神经肌肉功能及血浆药物水平
J Neurol Neurosurg Psychiatry. 1990 Jun;53(6):502-6. doi: 10.1136/jnnp.53.6.502.
4
Quantitative correlation between plasma pyridostigmine levels and neuromuscular function in myasthenia gravis.重症肌无力患者血浆吡啶斯的明水平与神经肌肉功能的定量相关性
Neurology. 1987 May;37(5):800-3. doi: 10.1212/wnl.37.5.800.
5
[Serum levels of pyridostigmine in myasthenia gravis: methods and clinical significance].[重症肌无力患者血清吡啶斯的明水平：方法及临床意义]
Fortschr Neurol Psychiatr. 1985 Jun;53(6):201-11. doi: 10.1055/s-2007-1001967.
6
Pyridostigmine levels in myasthenia gravis.重症肌无力患者的吡啶斯的明水平
Neurology. 1977 Nov;27(11):1099. doi: 10.1212/wnl.27.11.1099.
7
Plasma pyridostigmine levels in patients with myasthenia gravis.重症肌无力患者的血浆吡啶斯的明水平。
Clin Pharmacol Ther. 1977 Feb;21(2):187-93. doi: 10.1002/cpt1977212187.
8
9
Atypical myasthenia gravis. A neurophysiological and pharmacological study.
Electromyogr Clin Neurophysiol. 1975 Jul;15(3):271-7.
10
Neuromuscular blockade.
Surg Clin North Am. 1975 Aug;55(4):837-50. doi: 10.1016/s0039-6109(16)40685-7.
Zotero 插件